Difference between revisions of "Category:Antibody-drug conjugates"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) |
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Cytotoxic chemotherapy" to "[[Category:Cytotoxic chemotherapeutic") |
||
| Line 2: | Line 2: | ||
[[Category:Antineoplastic monoclonal antibodies]] | [[Category:Antineoplastic monoclonal antibodies]] | ||
| − | [[Category:Cytotoxic | + | [[Category:Cytotoxic chemotherapeutic]] |
Latest revision as of 18:13, 2 March 2020
A category of drugs composed of a monoclonal antibody coupled to a cytotoxic drug, usually of very high potency. The idea behind these drugs is that the cytotoxic drug is localized to the target by way of the monoclonal antibody, maximizing local effects while sparing systemic side effects. In reality these drugs are still fairly toxic.
Subcategories
This category has the following 11 subcategories, out of 11 total.
A
- Anti-BCMA antibody-drug conjugates
- Anti-CD19 antibody-drug conjugates
- Anti-CD22 antibody-drug conjugates
- Anti-CD30 antibody-drug conjugates
- Anti-CD33 antibody-drug conjugates
- Anti-CD79B antibody-drug conjugates
- Anti-FOLR1 antibody-drug conjugates
- Anti-HER2 antibody-drug conjugates
- Anti-nectin-4 antibody-drug conjugates
- Anti-TACSTD2 antibody-drug conjugates
- Anti-TF antibody-drug conjugates